AFP and hepatocellular carcinoma: Recently, a meta‐analysis reported that concomitant use of serum AFP with US could improve the sensitivity for early‐stage HCC from 45% to 63%; however, the role of serum AFP for surveillance of early‐stage HCC remains controversial.31, 32